Clinical Trial Update: Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery in Pregnant Patients at High Risk for Uterine Atony [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is recruiting to evaluate whether prophylactic intravenous calcium gluconate at cesarean delivery reduces blood loss in pregnant patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Atony

Drugs mentioned

• CALCIUM GLUCONATE (Calcium gluconate)

Snippet

Sponsor: University of Michigan | Conditions: Blood Loss, Surgical, Blood Loss, Postoperative | Phase 2 | Status: RECRUITING